MARKETS: Sensex rises 250 pts, Nifty above 17,200; auto, pharma stocks gain

Last Updated on January 27, 2023 by Admin

[ad_1]


Opening Bell

LIVE market updates: Indian equities started higher on Thursday amid mixed global cues. The started today’s session at 57,818 level, up 133 points or 0.2 per cent. The opened at 17,210, up 43 points.


M&M (up over 2 per cent), HDFC, Power Grid, Titan, and Sun Pharma were leading the list of gainers on the Sensex index. On the flipside, L&T (down 0.8 per cent), ICICI Bank, Nestle India, Axis Bank, and SBI were trading in the red.









In the broader markets, the BSE MidCap and SmallCap indices added 0.29 per cent and 0.22 per cent, respectively.


Among individual stocks, NDTV shares were locked at 5 per cent upper circuit after the company has signed an exclusive 10-year deal worth Rs 750 crore with Taboola – a global leader in powering content recommendations on the open web.


Raymond was trading flat with a positive bias even as the company’s board has approved the listing of its subsidiary JK Files & Engineering Ltd (JKFEL), a company that is in the business of auto parts.


Hero MotoCorp shares, meanwhile, were down half a per cent after the company reported a sharp 40.9 per cent YoY decline in November sales to 349,393 units as against 591,091 units sold in November 2020.




Sectorally, the Nifty Metal and Bank indices were down 0.5 per cent and 0.2 per cent, respectively. On the upside, the Nifty Auto and Pharma indices were up 0.7 per cent and 0.8 per cent, respectively.


=====================================================================

Pre-open session

LIVE market updates: Benchmark indices were trading with a positive bias in the pre-open session. The BSE Sensex was up 96 points at 57,781 levels at 9:07 AM while the was at17,183, up 16 points.


======================================================================

(Updated at 8:18 AM)

LIVE market updates: Lack of domestic triggers will keep investors hooked to global cues for trading on Thursday.


Stocks in Asia-Pacific were struggling for direction, as concerns over the economic impact of the omicron Covid variant continue to weigh on investor sentiment.




Hong Kong’s Hang Seng index rose 0.18 per cent, reversing earlier losses. Mainland Chinese stocks also recovered from earlier declines, with the Shanghai composite up 0.12 per cent and the Shenzhen component edged 0.178 per cent higher.



Elsewhere, the Nikkei 225 in Japan declined 1 per cent while the Topix index shed 0.7 per cent. South Korea’s Kospi rose 0.7 per cent.


Stocks on Wall Street saw a sharp reversal overnight after the Centers for Disease Control and Prevention confirmed the first case of omicron in the US.


The Dow Jones Industrial Average dropped 1.34 per cent while the S&P 500 declined 1.18 per cent. The Nasdaq Composite fell 1.83 per cent.


At 8:10 AM, SGX Nifty was at 17,146, compared with Nifty’s spot close of 17,167 of Wednesday.


Primary market


Star Health and Allied Insurance Company’s IPO is struggling to garner bids. The offering was subscribed 20 per cent on Wednesday at the end of Day 2 of its offer period.

Tega Industries IPO however was subscribed 4.7 times at the end of Day 1 itself. The retail portion was subscribed 7.5 times, and the wealth investor quota 4.2 times.


The wealth management arm of Anand Rathi Financial Services, Anand Rathi Wealth, will launch its initial public offering on Thursday. The price band for the offer has been fixed at Rs 530-550 per share and the company aims to mobilise Rs 660 crore.



mail Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor



[ad_2]

Source link